Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

盘前交易 06-17 04:08:46 EDT

0.6497

-0.0224

-3.33%

最高0.6723	最低0.6348	成交量54.03万
今开0.6723	昨收0.6721	日振幅5.58%
总市值2,674万	流通市值1,607万	总股本4,115万
成交额35.20万	换手率2.18%	流通股本2,473万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.6497,"timestamp":1718395200000,"preClose":0.6721,"halted":0,"volume":540334,"delay":0,"floatShares":24734252,"shares":41154799,"eps":-1.145647,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0224,"latestTime":"06-17 04:08:46 EDT","open":0.6723,"high":0.6723,"low":0.6348,"amount":351975.89103620005,"amplitude":0.055795,"askPrice":1,"askSize":100,"bidPrice":0.2813,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.145647,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1718631000000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.6497,"postHourTrading":{"tag":"盘后","latestPrice":0.64,"preClose":0.6497,"latestTime":"19:38 EDT","volume":8163,"amount":5253.2691,"timestamp":1718408294416},"volumeRatio":1.8079702748573208,"impliedVol":0.7497,"impliedVolPercentile":0.039},"requestUrl":"/m/hq/s/SPRB/tweets","defaultTab":"tweets","newsList":[{"id":"2443059056","title":"Spruce Biosciences, Inc.盘中异动 股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443059056","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443059056?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:30","pubTimestamp":1718386210,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时30分，Spruce Biosciences, Inc.股票出现异动，股价快速下跌5.55%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Nkgen Biotech Inc C/Wts 31/05/2028、Longeveron Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Longeveron Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2203.13%、1348.15%、262.45%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为129.28%、60.25%、58.87%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013011aef50d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013011aef50d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2439674658","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439674658","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439674658?lang=zh_cn&edition=full","pubTime":"2024-05-31 03:16","pubTimestamp":1717096610,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日03时16分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨5.15%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Summit Therapeutics Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为134.53%、74.66%、67.04%，振幅较大的相关个股有Summit Therapeutics Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Calidi Biotherapeutics, Inc.，振幅分别为237.48%、104.00%、93.84%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531031650941eb409&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531031650941eb409&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2439505173","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439505173","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439505173?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:29","pubTimestamp":1717003781,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时29分，Spruce Biosciences, Inc.股票出现异动，股价急速拉升5.09%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Onconetix, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Mustang Bio, Inc.、Onconetix, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为520.54%、138.58%、110.47%，振幅较大的相关个股有Onconetix, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为127.15%、117.00%、50.40%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012941af8af205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012941af8af205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2435300928","title":"斯普鲁斯生物科学公司（Spruce Biosciences Inc）报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435300928","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435300928?lang=zh_cn&edition=full","pubTime":"2024-05-14 04:46","pubTimestamp":1715633169,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc   报告了截至1月底的季度调整后每股亏损28美分，高于去年同期的每股-40美分。七位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-34美分至-19美分。* 营收同比增长 1.9%，达到 200 万美元；分析师预期为 116 万美元。* Spruce Biosciences Inc 公布的本季度每股收益为亏损 28 美分。* Spruce Biosciences Inc 本季度股价上涨了 6.0%，今年迄今为止亏损了 71.6%。* 生物技术和医学研究同行的平均一致建议也是 \"持有\"。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2434865774","title":"Spruce Biosciences Inc   预计每股亏损29美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434865774","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434865774?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:58","pubTimestamp":1715356720,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc    预计将在5月13日公布截至2024年3月31日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司预计营收将从去年同期的196万美元下降41.0%，至115.8万美元。* LSEG 分析师对 Spruce Biosciences Inc 的平均预期是每股亏损 29 美分。* 华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于其最新收盘价 0.84 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2429311590","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429311590","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429311590?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:17","pubTimestamp":1713881840,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时17分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨5.27%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Palisade Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2150.26%、170.92%、32.56%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Palisade Bio, Inc.、Immunitybio, Inc.，振幅分别为35.00%、32.86%、27.32%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232217217922b2c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232217217922b2c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2427600441","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.26%报0.698美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427600441","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427600441?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:15","pubTimestamp":1713190559,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时15分，Spruce Biosciences, Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报0.698美元/股，成交量30.9905万股，换手率0.75%，振幅5.69%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152215597a52dccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152215597a52dccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2422187945","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.27%报0.737美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422187945","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422187945?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:59","pubTimestamp":1711558789,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时59分，Spruce Biosciences, Inc.股票出现波动，股价急速拉升5.27%。截至发稿，该股报0.737美元/股，成交量91.9074万股，换手率2.23%，振幅5.71%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280059497a4f8e5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280059497a4f8e5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2422543914","title":"Spruce Biosciences, Inc.盘中异动 早盘快速下挫5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422543914","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422543914?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:52","pubTimestamp":1711374734,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时52分，Spruce Biosciences, Inc.股票出现波动，股价大幅跳水5.67%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252152147a4ee8c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252152147a4ee8c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2420728524","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.01%报0.711美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420728524","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420728524?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:47","pubTimestamp":1710942442,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时47分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.01%。截至发稿，该股报0.711美元/股，成交量34.3821万股，换手率0.84%，振幅7.62%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320214723861dfc2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320214723861dfc2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0403},{"period":"1month","weight":-0.1879},{"period":"3month","weight":-0.1959},{"period":"6month","weight":-0.6086},{"period":"1year","weight":-0.7247},{"period":"ytd","weight":-0.7783}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0646},{"period":"6month","weight":0.1565},{"period":"1year","weight":0.2263},{"period":"ytd","weight":0.1419}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.33989},{"month":2,"riseRate":0.5,"avgChangeRate":0.009378},{"month":3,"riseRate":0,"avgChangeRate":-0.297383},{"month":4,"riseRate":0,"avgChangeRate":-0.078867},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003763},{"month":6,"riseRate":0.25,"avgChangeRate":-0.082456},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.022894},{"month":8,"riseRate":0.333333,"avgChangeRate":0.005525},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.195471},{"month":10,"riseRate":0,"avgChangeRate":-0.297781},{"month":11,"riseRate":0.5,"avgChangeRate":0.017474},{"month":12,"riseRate":0.5,"avgChangeRate":0.416923}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况